Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Infectious Diseases

According to Reuters, GlaxoSmithKline’s experimental Ebola vaccine will be moving to the second phase of its trial and expanding to several additional countries in February 2015. Currently undergoing Phase I trials in the U.S., Switzerland, Britain...
A Phase III clinical trial for a shingles vaccine known as HZ/su involving over 16,000 people reduced the risk of shingles by 97.2 percent in adults ages 50 and older, Reuters reports. The vaccine, developed by GlaxoSmithKline, combines a protein found on...
According to CBS News, a new study shows that male Ebola survivors should make sure to wear condoms during sex for at least three months after recuperating from the illness. The study, published in Reproductive Sciences, confirmed the current...